NOVEL COMPOUND AND PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF
Provided is a compound represented by general formula (1) or a pharmaceutically-acceptable salt thereof. In formula (1), R1 and R2 may be the same or different from each other, and each represents a hydrogen atom, a halogen atom, a hydroxy group, a carboxy group, a cyano group, or an optionally-subs...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
09.08.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided is a compound represented by general formula (1) or a pharmaceutically-acceptable salt thereof. In formula (1), R1 and R2 may be the same or different from each other, and each represents a hydrogen atom, a halogen atom, a hydroxy group, a carboxy group, a cyano group, or an optionally-substituted C1-6 alkyl group or the like; R3 represents a hydrogen atom; R4 represents an optionally-substituted 4- to 10-membered monocyclic heterocyclic group containing 1-4 heteroatoms selected from an oxygen atom, a nitrogen atom, and a sulfur atom; X represents a group represented by -CH2-, -CH2-CH2-, -CH2-CH2-CH2-, or -CH2-O-CH2-; and Z represents a hydrogen atom or a hydroxy group.
本发明涉及一种下述通式(1)所表示的化合物或其药理学上所容许的盐。[式(1)中,R及R可以相同也可以不同,各自表示氢原子、卤原子、羟基、羧基、氰基、可经取代的C烷基等;R表示氢原子;R表示可经取代的包含选自氧原子、氮原子及硫原子中1~4个杂原子的4~10元的单环式杂环基;X表示下述式:-CH-、-CH-CH-、-CH-CH-CH-、或-CH-O-CH-所表示的基;Z表示氢原子或羟基]。 |
---|---|
Bibliography: | Application Number: CN201780080389 |